1 of 1
After an increasing number of complaints, drugmaker GSK announced it is voluntarily recalling nearly 600,000 Ventolin asthma inhalers from hospitals, pharmacies, wholesalers, and retailers throughout the United States. Check your medicine cabinets immediately!
The defect does not pose a danger to patients, so they are not being asked to return inhalers they have already purchased. The reason for the recall was that the affected products have a defect that causes them to deliver a smaller dose of medicine than indicated, which results from a leak in the propellant that delivers the medicine.